Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Jylamvo 2 mg/ml oral solution

Active Ingredient:
methotrexate
Company:  
Therakind Limited See contact details
ATC code: 
L04AX03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Product Information HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Jylamvo (methotrexate) – Patient Card - Risk Minimisation Information for Patients

The Patient Card contains important safety information the patient needs to be aware of when receiving treatment with Jylamvo (methotrexate).
{pdf_link}

Jylamvo (methotrexate) oral solution - Guide for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals
This Jylamvo (methotrexate) healthcare professional guide includes important information to minimise the risk of medication error

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Therakind Limited
Company image
Address
Third Floor, 314 Regents Park Road, London, N3 2JX, UK
WWW
http://www.therakind.com
Telephone
+44 (0)208 346 6035
Medical Information Direct Line
+44 (0)330 1359 437
Medical Information e-mail
[email protected]
Stock Availability
+44 (0)1628 771 800